Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Suspected colonic cancer turns out to be disseminated tuberculosis in a kidney transplant recipient: A case report.

Schmidt-Lauber C, Jacobi J, Polifka I, Hilgers KF, Wiesener MS.

Medicine (Baltimore). 2019 Sep;98(36):e16995. doi: 10.1097/MD.0000000000016995.

2.

Is Early Complement Activation in Renal Transplantation Associated with Later Graft Outcome?

Bobka S, Ebert N, Koertvely E, Jacobi J, Wiesener M, Büttner-Herold M, Amann K, Daniel C.

Kidney Blood Press Res. 2018;43(5):1488-1504. doi: 10.1159/000494014. Epub 2018 Oct 4.

3.

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.

Sommerer C, Witzke O, Lehner F, Arns W, Reinke P, Eisenberger U, Vogt B, Heller K, Jacobi J, Guba M, Stahl R, Hauser IA, Kliem V, Wüthrich RP, Mühlfeld A, Suwelack B, Duerr M, Paulus EM, Zeier M, Porstner M, Budde K; ZEUS and HERAKLES study investigators.

BMC Nephrol. 2018 Sep 19;19(1):237. doi: 10.1186/s12882-018-1031-1.

4.

Delayed graft function is associated with an increased rate of renal allograft rejection: A retrospective single center analysis.

Weber S, Dienemann T, Jacobi J, Eckardt KU, Weidemann A.

PLoS One. 2018 Jun 21;13(6):e0199445. doi: 10.1371/journal.pone.0199445. eCollection 2018.

5.

Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.

Sommerer C, Duerr M, Witzke O, Lehner F, Arns W, Kliem V, Ackermann D, Guba M, Jacobi J, Hauser IA, Stahl R, Reinke P, Rath T, Veit J, Mehrabi A, Porstner M, Budde K; HERAKLES Study Group.

Am J Transplant. 2018 Dec;18(12):2965-2976. doi: 10.1111/ajt.14897. Epub 2018 Jun 3.

6.

Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.

Budde K, Zeier M, Witzke O, Arns W, Lehner F, Guba M, Jacobi J, Kliem V, Reinke P, Hauser IA, Vogt B, Stahl R, Rath T, Duerr M, Paulus EM, May C, Porstner M, Sommerer C; HERAKLES Study Group.

Nephrol Dial Transplant. 2017 Jun 1;32(6):1060-1070. doi: 10.1093/ndt/gfx075.

PMID:
28605781
7.

Good outcome of brain stem progressive multifocal leukoencephalopathy in an immunosuppressed renal transplant patient: Importance of early detection and rapid immune reconstitution.

Sauer R, Gölitz P, Jacobi J, Schwab S, Linker RA, Lee DH.

J Neurol Sci. 2017 Apr 15;375:76-79. doi: 10.1016/j.jns.2017.01.046. Epub 2017 Jan 14.

PMID:
28320193
8.

Blunted transcriptional response to skeletal muscle ischemia in rats with chronic kidney disease: potential role for impaired ischemia-induced angiogenesis.

Heiss RU, Fahlbusch FB, Jacobi J, Daniel C, Ekici AB, Cordasic N, Amann K, Hartner A, Hilgers KF.

Physiol Genomics. 2017 Apr 1;49(4):230-237. doi: 10.1152/physiolgenomics.00124.2016. Epub 2017 Feb 17.

PMID:
28213570
9.

Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.

Schellinger IN, Cordasic N, Panesar J, Buchholz B, Jacobi J, Hartner A, Klanke B, Jakubiczka-Smorag J, Burzlaff N, Heinze E, Warnecke C, Raaz U, Willam C, Tsao PS, Eckardt KU, Amann K, Hilgers KF.

Kidney Int. 2017 Mar;91(3):616-627. doi: 10.1016/j.kint.2016.09.028. Epub 2016 Dec 4.

PMID:
27927598
10.

Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.

Hartner A, Jagusch L, Cordasic N, Amann K, Veelken R, Jacobi J, Hilgers KF.

Front Physiol. 2016 Aug 30;7:370. doi: 10.3389/fphys.2016.00370. eCollection 2016.

11.

Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program (ESP): A Single-Center Experience from 2008 to 2013.

Jacobi J, Beckmann S, Heller K, Hilgers KF, Apel H, Spriewald B, Eckardt KU, Amann KU.

Ann Transplant. 2016 Feb 11;21:94-104.

12.

Results of Renal Transplantation on Alloplastic Arterial Grafts.

Sagban TA, Regus S, Heller K, Jacobi J, Apel H, Keck B, Richterstetter M, Eckardt KU, Wullich B, Lang W.

Urol Int. 2016;96(2):157-63. doi: 10.1159/000443213. Epub 2016 Jan 13. Review.

PMID:
26756991
13.

Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.

Heim C, Gebhardt J, Ramsperger-Gleixner M, Jacobi J, Weyand M, Ensminger SM.

Heart Vessels. 2016 May;31(5):783-94. doi: 10.1007/s00380-015-0696-7. Epub 2015 Jun 11.

PMID:
26062773
14.

Donor acute kidney injury and short-term graft outcome in renal transplantation.

Jacobi J, Rebhan D, Heller K, Velden J, Hilgers KF, Wullich B, Eckardt KU, Amann KU.

Clin Transplant. 2014 Oct;28(10):1131-41. doi: 10.1111/ctr.12425. Epub 2014 Aug 19.

PMID:
25053244
15.

H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.

Eberhardt M, Dux M, Namer B, Miljkovic J, Cordasic N, Will C, Kichko TI, de la Roche J, Fischer M, Suárez SA, Bikiel D, Dorsch K, Leffler A, Babes A, Lampert A, Lennerz JK, Jacobi J, Martí MA, Doctorovich F, Högestätt ED, Zygmunt PM, Ivanovic-Burmazovic I, Messlinger K, Reeh P, Filipovic MR.

Nat Commun. 2014 Jul 15;5:4381. doi: 10.1038/ncomms5381.

16.

Effect of lowering asymmetric dimethylarginine (ADMA) on vascular pathology in atherosclerotic ApoE-deficient mice with reduced renal mass.

Jacobi J, Maas R, Arend M, Cordasic N, Hilgers KF.

Int J Mol Sci. 2014 Mar 31;15(4):5522-35. doi: 10.3390/ijms15045522.

17.

Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.

Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, Jadoul M, Ketteler M, Rump LC, Stenvinkel P, Westenfeld R, Wiecek A, Reinartz S, Hilgers RD, Floege J.

Nephrol Dial Transplant. 2014 Sep;29(9):1633-8. doi: 10.1093/ndt/gft459. Epub 2013 Nov 26.

PMID:
24285427
18.

BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.

Jacobi J, Prignitz A, Büttner M, Korn K, Weidemann A, Hilgers KF, Heller K, Velden J, Knöll A, Wullich B, May C, Eckardt KU, Amann KU.

BMC Nephrol. 2013 Oct 2;14:207. doi: 10.1186/1471-2369-14-207.

19.

A complex microdeletion 17q12 phenotype in a patient with recurrent de novo membranous nephropathy.

Hinkes B, Hilgers KF, Bolz HJ, Goppelt-Struebe M, Amann K, Nagl S, Bergmann C, Rascher W, Eckardt KU, Jacobi J.

BMC Nephrol. 2012 May 14;13:27. doi: 10.1186/1471-2369-13-27.

20.

Predominance of TH2 cells and plasma cells in polyoma virus nephropathy: a role for humoral immunity?

Buettner M, Xu H, Böhme R, Seliger B, Jacobi J, Wiesener M, Benz K, Amann K.

Hum Pathol. 2012 Sep;43(9):1453-62. doi: 10.1016/j.humpath.2011.11.006. Epub 2012 Mar 8.

PMID:
22406372

Supplemental Content

Loading ...
Support Center